Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked" (REREP2Y) does not correspond to a recognized gene, protein, or therapeutic target in major reference resources. Based on its name, it is classified as a pseudogene located on the Y chromosome that encodes sequences similar to arginine-glutamic acid dipeptide repeats. Pseudogenes are non-functional sequences of genomic DNA originally derived from functional genes but rendered inactive through mutation, deletion, or genomic rearrangement. While pseudogenes can sometimes regulate parental gene expression via RNA-mediated mechanisms, there is no evidence REREP2Y has any known biological activity, disease involvement, or pharmacological relevance[1][2][3]. This entry likely reflects a non-standard, hypothetical, or artifact designation rather than an established molecular target. The use of "pseudogene" in the name signifies it is not a protein-coding gene, functional receptor, enzyme, or drug target. If precise information is needed for biomedical applications, this entity should not be considered a valid molecular target.
Not applicable (not a therapeutic target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Arginine-glutamic acid dipeptide repeats pseudogene 2 Y-linked (REREP2Y).